Cantor Fitzgerald Analysts Reduce Earnings Estimates for Vaxcyte, Inc. (NASDAQ:PCVX)
Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) – Equities research analysts at Cantor Fitzgerald reduced their FY2023 earnings estimates for Vaxcyte in a research note issued on Tuesday, November 7th. Cantor Fitzgerald analyst L. Chen now expects that the company will earn ($3.33) per share for the year, down from their previous estimate of ($3.05). Cantor […]